Pathophysiology of genetic and experimental hypertension
- PMID: 2449990
Pathophysiology of genetic and experimental hypertension
Abstract
Evidence is summarized that some structural changes in resistance arteries (hyperplasia of smooth muscle and others) precede the development of vessel changes in genetic hypertension. Additional changes, such as hypertrophy of vascular muscle and altered collagen and elastin, accompany hypertension and contribute to its maintenance. Furthermore, some membrane defects, including reduced Ca2+-pumping by sarcolemma of vascular smooth muscle, contribute to the causation of genetic and experimental hypertension, as well as to some changes in hypertension associated with volume expansion. Analysis of these causative factors may aid in treatment and, ultimately, allow the prevention of hypertension.
Similar articles
-
Downregulation of the BK channel beta1 subunit in genetic hypertension.Circ Res. 2003 Nov 14;93(10):965-71. doi: 10.1161/01.RES.0000100068.43006.36. Epub 2003 Oct 9. Circ Res. 2003. PMID: 14551242
-
Pathophysiology of vascular smooth muscle in hypertension.J Hypertens Suppl. 1984 Dec;2(3):S413-20. J Hypertens Suppl. 1984. PMID: 6400380 Review. No abstract available.
-
Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats.Br J Pharmacol. 1997 Jan;120(1):65-73. doi: 10.1038/sj.bjp.0700857. Br J Pharmacol. 1997. PMID: 9117100 Free PMC article.
-
Vascular smooth muscle in hypertension.Fed Proc. 1982 Jun;41(8):2387-93. Fed Proc. 1982. PMID: 6282652
-
Vascular smooth muscle calcium channels.J Cardiovasc Pharmacol. 1987;10 Suppl 10:S10-6. J Cardiovasc Pharmacol. 1987. PMID: 2455103 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous